drugset / Trial / NCT04308343
The Aromatase Inhibitor and Gnrh Antagonist Versus Methotrexate for Management of Undisturbed Ectopic Pregnancy
RandomizedParallel-groupSingle-blindTreatment
Summary
The aim of this study is to : 1. Use of the aromatase inhibitor( letrozole) for the treatment of ectopic pregnancy compared to methotrexate. 2. Use of the Gnrh antagonist for the treatment of ectopic pregnancy compared to methotrexate.
Timeline
- Start
- 2020-03-30
- Primary completion
- 2022-03-01
- Completion
- 2022-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cetrorelix | Other / unclassified | — | — |
| Comparator | Letrozole | Other / unclassified | — | — |
| Comparator | Methotrexate | Small molecule | — | — |